BR (Broadridge Financial Solutions Inc)
Insider Trading Activity
Every open-market purchase and sale reported by BR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | CHRISTOPHER JOHN PERRY | President | A | — | — |
| 2026-08-14 | DOUGLAS RICHARD DESCHUTTER | Co-President ICS | A | — | — |
| 2026-08-14 | Thomas P Carey | Corporate VP | A | — | — |
| 2026-08-14 | Ashima Ghei | CFO | A | — | — |
| 2026-08-14 | Timothy C Gokey | CEO | A | — | — |
| 2026-08-14 | Richard John Stingi | Corporate VP and CHRO | A | — | — |
| 2026-08-10 | Robert N Duelks | Director | Sell | — | — |
| 2026-07-06 | MELVIN L FLOWERS | Director | A | — | — |
| 2026-07-06 | EILEEN K MURRAY | Director | A | — | — |
| 2026-07-06 | Amit Zavery | Director | A | — | — |
| 2026-07-06 | Annette L. Nazareth | Director | A | — | — |
| 2026-07-06 | Maura A. Markus | Director | A | — | — |
| 2026-07-06 | Patricia Ann Mosconi | Director | A | — | — |
| 2026-07-06 | Robert N Duelks | Director | A | — | — |
| 2026-06-29 | Ashima Ghei | CFO | MIXED | — | — |
| 2026-06-11 | Annette L. Nazareth | Director | A | — | — |
| 2026-06-11 | Maura A. Markus | Director | A | — | — |
| 2026-06-11 | EILEEN K MURRAY | Director | A | — | — |
| 2026-06-11 | Amit Zavery | Director | A | — | — |
| 2026-06-11 | Patricia Ann Mosconi | Director | A | — | — |
| 2026-06-05 | Hope M. Jarkowski | Chief Legal Officer | Sell | — | — |
| 2026-04-09 | Robert N Duelks | Director | A | — | — |
| 2026-04-09 | MELVIN L FLOWERS | Director | A | — | — |
| 2026-04-09 | brett keller | Director | A | — | — |
| 2026-04-09 | Maura A. Markus | Director | A | — | — |
| 2026-04-09 | Patricia Ann Mosconi | Director | A | — | — |
| 2026-04-09 | EILEEN K MURRAY | Director | A | — | — |
| 2026-04-09 | Annette L. Nazareth | Director | A | — | — |
| 2026-04-09 | Amit Zavery | Director | A | — | — |
| 2026-04-08 | brett keller | Director | A | — | — |
| 2026-04-08 | EILEEN K MURRAY | Director | A | — | — |
| 2026-04-08 | Annette L. Nazareth | Director | A | — | — |
| 2026-04-08 | Amit Zavery | Director | A | — | — |
| 2026-04-08 | Maura A. Markus | Director | A | — | — |
| 2026-04-02 | Hope M. Jarkowski | Chief Legal Officer | MIXED | — | — |
| 2026-03-09 | Timothy C Gokey | CEO | Buy | — | — |
| 2026-03-06 | Patricia Ann Mosconi | Director | A | — | — |
| 2026-03-06 | Thomas P Carey | Corporate VP | A | — | — |
| 2026-03-06 | DOUGLAS RICHARD DESCHUTTER | Co-President ICS | A | — | — |
| 2026-03-06 | Ashima Ghei | Interim CFO | A | — | — |
| 2026-03-06 | Timothy C Gokey | CEO | A | — | — |
| 2026-03-06 | Hope M. Jarkowski | Chief Legal Officer | A | — | — |
| 2026-03-06 | CHRISTOPHER JOHN PERRY | President | A | — | — |
| 2026-03-06 | Richard John Stingi | Corporate VP and CHRO | A | — | — |
| 2026-03-03 | Robert N Duelks | Director | G | — | — |
| 2026-02-25 | Robert N Duelks | Director | D | — | — |
| 2026-02-06 | Robert N Duelks | Director | Sell | — | — |
| 2026-01-06 | Robert N Duelks | Director | A | — | — |
| 2026-01-06 | MELVIN L FLOWERS | Director | A | — | — |
| 2026-01-06 | brett keller | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Executive Chairman | 212,749 | — |
| — | CEO | 176,141 | — |
| — | Corporate SVP | 123,575 | — |
| — | President | 119,546 | — |
| — | Executive Chairman | 118,489 | — |
| — | Corporate Vice President | 88,076 | — |
| — | Corporate Vice President | 83,254 | — |
| — | Director | 77,433 | — |
| — | Director | 74,464 | — |
| — | Corporate Vice President | 56,745 | — |
| — | President | 54,136 | — |
| — | Director | 47,900 | — |
| — | Director | 46,594 | — |
| — | Corporate SVP and CFO | 34,769 | — |
| — | Director | 32,718 | — |
| — | Corporate Vice President | 30,554 | — |
| — | Director | 30,061 | — |
| — | Director | 30,000 | — |
| — | Director | 29,415 | — |
| — | Corporate Vice President | 26,867 | — |
| — | Corporate Vice President | 22,134 | — |
| — | Corporate Vice President | 18,708 | — |
| — | Corporate Vice President | 18,128 | — |
| — | Co-President ICS | 18,046 | — |
| — | Director | 16,942 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BR quote page; the site-wide leaderboard is on the insider transactions hub.